Citadel Advisors LLC 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:16 pm Sale |
2024-09-30 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 22 0.000% |
-1,556,820 (-100.00%) |
Filing |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 1,556,842 5.200% |
219,849 (+16.44%) |
Filing |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 1,336,993 6.900% |
-24 (-0.00%) |
Filing |
| 2022-04-08 4:11 pm Purchase |
2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 1,337,017 7.100% |
1,337,017 (New Position) |
Filing |